1035 related articles for article (PubMed ID: 9808873)
41. Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction.
Merlini PA; Cugno M; Rossi ML; Agricola P; Repetto A; Fetiveau R; Diotallevi P; Canosi U; Mannucci PM; Ardissino D
Am J Cardiol; 2004 Apr; 93(7):822-5. PubMed ID: 15050482
[TBL] [Abstract][Full Text] [Related]
42. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
Grajek S; Lesiak M; Araszkiewicz A; Pyda M; Skorupski W; Grygier M; Mitkowski P; Prech M; Baszko A; Janus M; Breborowicz P; Rzeźniczak J; Tarchalski J; Główka A; Cieśliński A
Kardiol Pol; 2008 Feb; 66(2):154-63; discussion 164-5. PubMed ID: 18344153
[TBL] [Abstract][Full Text] [Related]
43. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
44. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
[TBL] [Abstract][Full Text] [Related]
45. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
[TBL] [Abstract][Full Text] [Related]
46. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
[TBL] [Abstract][Full Text] [Related]
47. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality].
Charbonnier B
Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411
[TBL] [Abstract][Full Text] [Related]
48. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
[TBL] [Abstract][Full Text] [Related]
49. [Advantages of immediate coronary dilatation after thrombolysis using tissue-type plasminogen activator in acute myocardial infarction. A European Cooperative Group trial].
Vahanian A
Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():39-43. PubMed ID: 2973300
[TBL] [Abstract][Full Text] [Related]
50. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL
Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606
[TBL] [Abstract][Full Text] [Related]
51. In vivo platelet activation following myocardial infarction and acute coronary ischaemia.
Hughes A; Daunt S; Vass G; Wickes J
Thromb Haemost; 1982 Oct; 48(2):133-5. PubMed ID: 6184842
[TBL] [Abstract][Full Text] [Related]
52. Time course of platelet alpha granule release in acute myocardial infarction treated with streptokinase.
Frandsen NJ; Winther K; Pedersen F; Christiansen I; McNair P
Heart; 1996 Feb; 75(2):141-4. PubMed ID: 8673751
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the kinetics of MB creatine kinase in patients undergoing systemic thrombolytic therapy].
Arrigo F; Saccà CM; Cavalli A; Egitto M; Barillari M; Costa G; Cavalli G; Carerj S; Melluso C
Cardiologia; 1991 Nov; 36(11):861-6. PubMed ID: 1817758
[TBL] [Abstract][Full Text] [Related]
54. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
López Bescós L
Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
[TBL] [Abstract][Full Text] [Related]
55. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
56. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
[TBL] [Abstract][Full Text] [Related]
57. Coronary thrombolysis: practical considerations.
Eisenberg PR; Jaffe AS
Cardiol Clin; 1987 Feb; 5(1):129-41. PubMed ID: 3103918
[TBL] [Abstract][Full Text] [Related]
58. Beta-thromboglobulin plasma levels in the first week after myocardial infarction: influence of thrombolytic therapy.
Salvioni A; Marenzi G; Lauri G; Giraldi F; Perego GB; Grazi S; Guazzi MD
Am Heart J; 1994 Sep; 128(3):472-6. PubMed ID: 8074007
[TBL] [Abstract][Full Text] [Related]
59. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
60. [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].
Acar J; Dorent R; Vahanian A; Michel PL; Cormier B; Slama M; Cazaux P; Conard J; Verdy E; Samama M
Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():59-65. PubMed ID: 3142430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]